ID   MSMO1_HUMAN             Reviewed;         293 AA.
AC   Q15800; A8K8Q3; A8MYF6; D3DP32; Q32Q24;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   10-MAY-2017, entry version 155.
DE   RecName: Full=Methylsterol monooxygenase 1;
DE            EC=1.14.13.72 {ECO:0000250|UniProtKB:P53045};
DE   AltName: Full=C-4 methylsterol oxidase;
GN   Name=MSMO1; Synonyms=DESP4, ERG25, SC4MOL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Intestine;
RX   PubMed=8663358; DOI=10.1074/jbc.271.28.16927;
RA   Li L., Kaplan J.;
RT   "Characterization of yeast methyl sterol oxidase (ERG25) and
RT   identification of a human homologue.";
RL   J. Biol. Chem. 271:16927-16933(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RA   Herrmann K.;
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Corpus callosum, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   INVOLVEMENT IN MCCPD, AND VARIANTS MCCPD GLN-173 AND CYS-244.
RX   PubMed=21285510; DOI=10.1172/JCI42650;
RA   He M., Kratz L.E., Michel J.J., Vallejo A.N., Ferris L., Kelley R.I.,
RA   Hoover J.J., Jukic D., Gibson K.M., Wolfe L.A., Ramachandran D.,
RA   Zwick M.E., Vockley J.;
RT   "Mutations in the human SC4MOL gene encoding a methyl sterol oxidase
RT   cause psoriasiform dermatitis, microcephaly, and developmental
RT   delay.";
RL   J. Clin. Invest. 121:976-984(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   VARIANT MCCPD ARG-115.
RX   PubMed=24144731; DOI=10.1016/j.bbalip.2013.10.009;
RA   He M., Smith L.D., Chang R., Li X., Vockley J.;
RT   "The role of sterol-C4-methyl oxidase in epidermal biology.";
RL   Biochim. Biophys. Acta 1841:331-335(2014).
CC   -!- FUNCTION: Catalyzes the first step in the removal of the two C-4
CC       methyl groups of 4,4-dimethylzymosterol.
CC       {ECO:0000250|UniProtKB:P53045}.
CC   -!- CATALYTIC ACTIVITY: 4,4-dimethyl-5-alpha-cholest-7-en-3-beta-ol +
CC       NAD(P)H + O(2) = 4-beta-hydroxymethyl-4-alpha-methyl-5-alpha-
CC       cholest-7-en-3-beta-ol + NAD(P)(+) + H(2)O.
CC       {ECO:0000250|UniProtKB:P53045}.
CC   -!- CATALYTIC ACTIVITY: 4-beta-hydroxymethyl-4-alpha-methyl-5-alpha-
CC       cholest-7-en-3-beta-ol + NAD(P)H + O(2) = 3-beta-hydroxy-4-beta-
CC       methyl-5-alpha-cholest-7-ene-4-alpha-carbaldehyde + NAD(P)(+) + 2
CC       H(2)O. {ECO:0000250|UniProtKB:P53045}.
CC   -!- CATALYTIC ACTIVITY: 3-beta-hydroxy-4-beta-methyl-5-alpha-cholest-
CC       7-ene-4-alpha-carbaldehyde + NAD(P)H + O(2) = 3-beta-hydroxy-4-
CC       beta-methyl-5-alpha-cholest-7-ene-4-alpha-carboxylate + NAD(P)(+)
CC       + H(2)O. {ECO:0000250|UniProtKB:P53045}.
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC         Evidence={ECO:0000250|UniProtKB:P53045};
CC   -!- PATHWAY: Steroid biosynthesis; zymosterol biosynthesis; zymosterol
CC       from lanosterol: step 3/6.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15800-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15800-2; Sequence=VSP_044585;
CC   -!- DOMAIN: The histidine box domains may contain the active site
CC       and/or be involved in metal ion binding.
CC   -!- DISEASE: Microcephaly, congenital cataract, and psoriasiform
CC       dermatitis (MCCPD) [MIM:616834]: An autosomal recessive inborn
CC       error of cholesterol metabolism characterized by accumulation of a
CC       large amount of methylsterols, particularly dimethylsterols, in
CC       affected individuals. Patients manifest psoriasiform dermatitis,
CC       arthralgias, congenital cataracts, microcephaly, and developmental
CC       delay. {ECO:0000269|PubMed:21285510, ECO:0000269|PubMed:24144731}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the sterol desaturase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U60205; AAC50587.1; -; mRNA.
DR   EMBL; U93162; AAB81566.1; -; mRNA.
DR   EMBL; AK292418; BAF85107.1; -; mRNA.
DR   EMBL; AK295432; BAH12066.1; -; mRNA.
DR   EMBL; AC012504; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471056; EAX04820.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX04821.1; -; Genomic_DNA.
DR   EMBL; BC010653; AAH10653.1; -; mRNA.
DR   EMBL; BC107879; AAI07880.1; -; mRNA.
DR   CCDS; CCDS3809.1; -. [Q15800-1]
DR   CCDS; CCDS43280.1; -. [Q15800-2]
DR   RefSeq; NP_001017369.1; NM_001017369.2. [Q15800-2]
DR   RefSeq; NP_006736.1; NM_006745.4. [Q15800-1]
DR   RefSeq; XP_005263233.1; XM_005263176.2. [Q15800-1]
DR   UniGene; Hs.105269; -.
DR   ProteinModelPortal; Q15800; -.
DR   BioGrid; 112214; 12.
DR   IntAct; Q15800; 2.
DR   MINT; MINT-2862749; -.
DR   STRING; 9606.ENSP00000261507; -.
DR   DrugBank; DB00157; NADH.
DR   SwissLipids; SLP:000001244; -.
DR   iPTMnet; Q15800; -.
DR   PhosphoSitePlus; Q15800; -.
DR   SwissPalm; Q15800; -.
DR   BioMuta; MSMO1; -.
DR   DMDM; 2498340; -.
DR   EPD; Q15800; -.
DR   MaxQB; Q15800; -.
DR   PaxDb; Q15800; -.
DR   PeptideAtlas; Q15800; -.
DR   PRIDE; Q15800; -.
DR   DNASU; 6307; -.
DR   Ensembl; ENST00000261507; ENSP00000261507; ENSG00000052802. [Q15800-1]
DR   Ensembl; ENST00000393766; ENSP00000377361; ENSG00000052802. [Q15800-2]
DR   GeneID; 6307; -.
DR   KEGG; hsa:6307; -.
DR   UCSC; uc003ire.4; human. [Q15800-1]
DR   CTD; 6307; -.
DR   DisGeNET; 6307; -.
DR   GeneCards; MSMO1; -.
DR   HGNC; HGNC:10545; MSMO1.
DR   HPA; HPA056127; -.
DR   MalaCards; MSMO1; -.
DR   MIM; 607545; gene.
DR   MIM; 616834; phenotype.
DR   neXtProt; NX_Q15800; -.
DR   OpenTargets; ENSG00000052802; -.
DR   PharmGKB; PA34955; -.
DR   eggNOG; KOG0873; Eukaryota.
DR   eggNOG; COG3000; LUCA.
DR   GeneTree; ENSGT00530000063017; -.
DR   HOGENOM; HOG000162289; -.
DR   HOVERGEN; HBG051504; -.
DR   InParanoid; Q15800; -.
DR   KO; K07750; -.
DR   OMA; DSQYVAY; -.
DR   OrthoDB; EOG091G0BM3; -.
DR   PhylomeDB; Q15800; -.
DR   TreeFam; TF354294; -.
DR   BioCyc; MetaCyc:HS00650-MONOMER; -.
DR   BRENDA; 1.14.13.72; 2681.
DR   Reactome; R-HSA-191273; Cholesterol biosynthesis.
DR   UniPathway; UPA00770; UER00756.
DR   ChiTaRS; MSMO1; human.
DR   GenomeRNAi; 6307; -.
DR   PRO; PR:Q15800; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000052802; -.
DR   CleanEx; HS_SC4MOL; -.
DR   ExpressionAtlas; Q15800; baseline and differential.
DR   Genevisible; Q15800; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:ProtInc.
DR   GO; GO:0000254; F:C-4 methylsterol oxidase activity; IBA:GO_Central.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome.
DR   GO; GO:0006631; P:fatty acid metabolic process; TAS:ProtInc.
DR   GO; GO:0008202; P:steroid metabolic process; TAS:ProtInc.
DR   GO; GO:0016126; P:sterol biosynthetic process; IBA:GO_Central.
DR   InterPro; IPR006694; Fatty_acid_hydroxylase.
DR   Pfam; PF04116; FA_hydroxylase; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cataract; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Iron; Lipid biosynthesis; Lipid metabolism;
KW   Membrane; NAD; Oxidoreductase; Polymorphism; Reference proteome;
KW   Steroid biosynthesis; Steroid metabolism; Sterol biosynthesis;
KW   Sterol metabolism; Transmembrane; Transmembrane helix.
FT   CHAIN         1    293       Methylsterol monooxygenase 1.
FT                                /FTId=PRO_0000117033.
FT   TRANSMEM     55     75       Helical. {ECO:0000255}.
FT   TRANSMEM    100    120       Helical. {ECO:0000255}.
FT   TRANSMEM    199    219       Helical. {ECO:0000255}.
FT   MOTIF       157    161       Histidine box-1.
FT   MOTIF       170    174       Histidine box-2.
FT   MOTIF       249    255       Histidine box-3.
FT   VAR_SEQ       1    131       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044585.
FT   VARIANT     115    115       G -> R (in MCCPD; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:24144731}.
FT                                /FTId=VAR_076531.
FT   VARIANT     124    124       N -> S (in dbSNP:rs34499452).
FT                                /FTId=VAR_048898.
FT   VARIANT     173    173       H -> Q (in MCCPD; dbSNP:rs869025576).
FT                                {ECO:0000269|PubMed:21285510}.
FT                                /FTId=VAR_076532.
FT   VARIANT     244    244       Y -> C (in MCCPD; dbSNP:rs760048191).
FT                                {ECO:0000269|PubMed:21285510}.
FT                                /FTId=VAR_076533.
SQ   SEQUENCE   293 AA;  35216 MW;  D88E0DDBE85DE0BF CRC64;
     MATNESVSIF SSASLAVEYV DSLLPENPLQ EPFKNAWNYM LNNYTKFQIA TWGSLIVHEA
     LYFLFCLPGF LFQFIPYMKK YKIQKDKPET WENQWKCFKV LLFNHFCIQL PLICGTYYFT
     EYFNIPYDWE RMPRWYFLLA RCFGCAVIED TWHYFLHRLL HHKRIYKYIH KVHHEFQAPF
     GMEAEYAHPL ETLILGTGFF IGIVLLCDHV ILLWAWVTIR LLETIDVHSG YDIPLNPLNL
     IPFYAGSRHH DFHHMNFIGN YASTFTWWDR IFGTDSQYNA YNEKRKKFEK KTE
//
